Peregrine Pharmaceuticals traded at $19.27 this Wednesday August 10th, increasing $1.61 or 9.12 percent since the previous trading session. Looking back, over the last four weeks, Peregrine Pharmaceuticals gained 8.75 percent. Over the last 12 months, its price fell by 17.15 percent. Looking ahead, we forecast Peregrine Pharmaceuticals to be priced at 18.82 by the end of this quarter and at 17.30 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agenus 2.67 0.11 4.30% -54.36%
Amgen 252.09 3.73 1.50% 10.50%
AstraZeneca 10,690.00 -128.00 -1.18% 28.81%
BioCryst Pharmaceuticals 14.76 0.31 2.15% -5.23%
Bristol-Myers Squibb 74.86 -0.10 -0.13% 11.95%
ChemoCentryx 50.87 0.08 0.16% 253.02%
Celldex Therapeutics 37.32 2.04 5.78% -13.73%
GlaxoSmithKline 1,442.20 -114.40 -7.35% -2.16%
Immunogen 5.31 0.04 0.76% -8.92%
Karyopharm Therapeutics 5.20 0.29 5.91% -0.57%
Eli Lilly 304.61 1.59 0.52% 15.34%
MacroGenics 4.98 -0.12 -2.35% -79.84%
MannKind 4.29 0.20 4.89% 7.52%
Merck & Co 89.19 -0.33 -0.37% 18.59%
Minerva Neurosciences 3.42 -0.18 -5.00% 102.37%
Lumos Pharma Inc. 8.31 0.21 2.59% 11.99%
Novartis 81.71 -0.80 -0.97% -4.70%
Novavax 41.36 1.08 2.68% -82.35%
Peregrine Pharmaceuticals 19.27 1.61 9.12% -17.15%
Repligen 256.21 11.36 4.64% 2.63%
Roche Holding 313.95 -3.00 -0.95% -14.43%
Xencor 30.43 1.22 4.18% -4.43%
Intrexon 2.42 0.11 4.76% -60.59%

Indexes Price Day Year
USND 12855 360.88 2.89% -12.94%
US2000 1969 56.36 2.95% -12.49%

Peregrine Pharmaceuticals
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.